Jubilant Pharmova eyes $150 million through rupee debt sale, bankers say
It plans to raise around ₹1,400 crore (around $150 million) through the sale of three-year bonds with bullet maturity
We haven't written up this one. Hindu BusinessLine has the full story — the link below goes straight to it.